INTRODUCTION {#sec1-1}
============

Proline-rich peptides are an important ingredient of a balanced human diet. The modern Western diet is often lacking in these peptides. While dairy products are a major traditional source of these peptides, other low-cost potential sources for dietary supplementation are desirable.

The concept of "bioprospecting" for bioactive peptides from keratin-containing materials such as wool, hair, skin and feathers presents an exciting opportunity for discovery and value-addition. The published literature (scientific and patent) reports multiple examples of proline-rich peptides with protective bioactivity in models of human disease, including tumor formation, hypertension control and Alzheimer's disease. Bioactive peptides have been identified from food and other protein sources. However, the bioactivity of keratin-related proteins and peptides is largely unknown.

Considering the high representation of proline-rich peptides among proven bioactive peptides \[[Table 1](#T0001){ref-type="table"}\], the proline-rich character of keratinous proteins supports their focus for biodiscovery research.

###### 

Selection of known proline-rich peptides and related bioactives

  Disease state         Substrate and bioactive peptide                   Activity                                        Reference
  --------------------- ------------------------------------------------- ----------------------------------------------- -----------------------
  Hypertension          Bovine casein:VPP, IPP                            Angiotensin converting enzyme (ACE) inhibitor   Mizuno*et al.* (2004)
  Alzheimer's disease   Sheep colostrum: 'Clostrinin ^TM^'                Beta sheet breaker (amyloid fibrils)            Inglot *et al.*(1996)
  Colo-rectal cancer    Epithelial cellular proline-rich acidic protein   Epithelial cell growth homeostasis              Zhang *et al.* (2003)

MATERIALS AND METHODS {#sec1-2}
=====================

A selection of mammalian (cow epidermis, sheep wool) and avian (chicken feather) keratinous materials were subjected to enzymatic hydrolysis using established processing methods for library production.

A bioassay for determining inhibition of early-stage amyloid aggregation involved using a model fibril-forming protein (reduced and carboxymethylated bovine kappa-casein, RCM kappa-CN) and quantification of fibril development with the amyloid-specific fluorophore, Thioflavin T (ThT, see [Figure 1](#F0001){ref-type="fig"}). Progressive aggregation of RCK kappa-CN was routinely monitored over 1,000 min by changes in fluorescence (440 nm excitation, 490 nm emission). The assay was fully validated for analytical repeatability and used together with appropriate positive controls.

![Schematic representation of the principle of the ThT fluorescence-based assay for monitoring assembly of beta-sheet structures associated with amyloid fibril growth](IJT-2-47-g001){#F0001}

RESULTS AND DISCUSSION {#sec1-3}
======================

Peptide library products derived from chicken feather (*n*=9), sheep wool (*n*=9) and bovine epidermis (*n*=9) were screened in the fibril inhibition assay based on kappa-casein. Twenty-seven products were identified; three exhibited sufficient bioactivity to warrant enrichment and identification of active peptides within this sample set \[[Figure 2](#F0002){ref-type="fig"}\].

![Dose-dependent inhibition of kappa-casein fibril assembly by peptide extracts](IJT-2-47-g002){#F0002}

Results from the primary screening of keratinous peptide libraries in assays related to hypertension, including ACE inhibition and angiotensin II receptor inhibition, also indicate promising bioactivity. As fibril inhibition requires stoichiometric interaction between peptide and kappa-CN, the bioactivity is likely to be associated with most abundant peptides.

High-performance liquid chromatography was used to provide an indication of the complexity of the assemblage of peptides in the three active products \[[Figure 3](#F0003){ref-type="fig"}\].

![Phase high-performance liquid chromatography fingerprint profiles of lead antifibril products](IJT-2-47-g003){#F0003}

CONCLUSIONS {#sec1-4}
===========

Keratinous containing substances such as feather, wool and skin, often discarded after animal slaughter, can now be considered as important future neutraceuticals.

Furthermore, the model systems currently used allow characterization of the molecular properties of fibril-inhibiting peptides and will allow us to elucidate the mechanism and molecular properties of the keratinous peptides responsible for fibril inhibition. Bioprospecting research using keratinous materials facilitates the discovery of useful bioactives in research and product development.
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